Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the three research firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and two have given a buy rating to the company. The average […]